REPORT ID 4875

Asia-Pacific Seasonal Influenza Vaccine Market Report 2017

Publish Date
19-Dec-17
Pages
112
Format
Electronic (PDF)

In this report, the Asia-Pacific Seasonal Influenza Vaccine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split Asia-Pacific into several key Regions, with sales (K Doses), revenue (Million USD), market share and growth rate of Seasonal Influenza Vaccine for these regions, from 2012 to 2022 (forecast), including
    China
    Japan
    South Korea
    Taiwan
    India
    Southeast Asia
    Australia

Asia-Pacific Seasonal Influenza Vaccine market competition by top manufacturers/players, with Seasonal Influenza Vaccine sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    GSK
    Sinovac
    Changsheng
    CCBIO
    Aleph Biomedical
    Sanofi
    Lanzhou Institute Of Biological Product
    Siobp
    Hualan Bio
    Tianyuan Bio-Pharma
    Vaxtec
    Hissen
    Abbott
    Novartis
    Tasly&Jenner
    Tiantan

On the basis of product, this report displays the sales volum, revenue, product price, market share and growth rate of each type, primarily split into
    Trivalent Influenza Vaccine
    Quadrivalent Influenza Vaccine
    Other

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Children
    Adults
    Elderly
    Pregnancy

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Asia-Pacific Seasonal Influenza Vaccine Market Report 2017
1 Seasonal Influenza Vaccine Overview
    1.1 Product Overview and Scope of Seasonal Influenza Vaccine
    1.2 Classification of Seasonal Influenza Vaccine by Product Category
        1.2.1 Asia-Pacific Seasonal Influenza Vaccine Market Size (Sales) Comparison by Types (2012-2022)
        1.2.2 Asia-Pacific Seasonal Influenza Vaccine Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Trivalent Influenza Vaccine
        1.2.4 Quadrivalent Influenza Vaccine
        1.2.5 Other
    1.3 Asia-Pacific Seasonal Influenza Vaccine Market by Application/End Users
        1.3.1 Asia-Pacific Seasonal Influenza Vaccine Sales (Volume) and Market Share Comparison by Applications (2012-2022)
        1.3.2 Children
        1.3.3 Adults
        1.3.4 Elderly
        1.3.5 Pregnancy
    1.4 Asia-Pacific Seasonal Influenza Vaccine Market by Region
        1.4.1 Asia-Pacific Seasonal Influenza Vaccine Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 China Status and Prospect (2012-2022)
        1.4.3 Japan Status and Prospect (2012-2022)
        1.4.4 South Korea Status and Prospect (2012-2022)
        1.4.5 Taiwan Status and Prospect (2012-2022)
        1.4.6 India Status and Prospect (2012-2022)
        1.4.7 Southeast Asia Status and Prospect (2012-2022)
        1.4.8 Australia Status and Prospect (2012-2022)
    1.5 Asia-Pacific Market Size (Value and Volume) of Seasonal Influenza Vaccine (2012-2022)
        1.5.1 Asia-Pacific Seasonal Influenza Vaccine Sales and Growth Rate (2012-2022)
        1.5.2 Asia-Pacific Seasonal Influenza Vaccine Revenue and Growth Rate (2012-2022)

2 Asia-Pacific Seasonal Influenza Vaccine Competition by Players/Suppliers, Region, Type and Application
    2.1 Asia-Pacific Seasonal Influenza Vaccine Market Competition by Players/Suppliers
        2.1.1 Asia-Pacific Seasonal Influenza Vaccine Sales Volume and Market Share of Key Players/Suppliers (2012-2017)
        2.1.2 Asia-Pacific Seasonal Influenza Vaccine Revenue and Share by Players/Suppliers (2012-2017)
    2.2 Asia-Pacific Seasonal Influenza Vaccine (Volume and Value) by Type
        2.2.1 Asia-Pacific Seasonal Influenza Vaccine Sales and Market Share by Type (2012-2017)
        2.2.2 Asia-Pacific Seasonal Influenza Vaccine Revenue and Market Share by Type (2012-2017)
    2.3 Asia-Pacific Seasonal Influenza Vaccine (Volume) by Application
    2.4 Asia-Pacific Seasonal Influenza Vaccine (Volume and Value) by Region
        2.4.1 Asia-Pacific Seasonal Influenza Vaccine Sales and Market Share by Region (2012-2017)
        2.4.2 Asia-Pacific Seasonal Influenza Vaccine Revenue and Market Share by Region (2012-2017)

3 China Seasonal Influenza Vaccine (Volume, Value and Sales Price)
    3.1 China Seasonal Influenza Vaccine Sales and Value (2012-2017)
        3.1.1 China Seasonal Influenza Vaccine Sales Volume and Growth Rate (2012-2017)
        3.1.2 China Seasonal Influenza Vaccine Revenue and Growth Rate (2012-2017)
        3.1.3 China Seasonal Influenza Vaccine Sales Price Trend (2012-2017)
    3.2 China Seasonal Influenza Vaccine Sales Volume and Market Share by Type
    3.3 China Seasonal Influenza Vaccine Sales Volume and Market Share by Application

4 Japan Seasonal Influenza Vaccine (Volume, Value and Sales Price)
    4.1 Japan Seasonal Influenza Vaccine Sales and Value (2012-2017)
        4.1.1 Japan Seasonal Influenza Vaccine Sales Volume and Growth Rate (2012-2017)
        4.1.2 Japan Seasonal Influenza Vaccine Revenue and Growth Rate (2012-2017)
        4.1.3 Japan Seasonal Influenza Vaccine Sales Price Trend (2012-2017)
    4.2 Japan Seasonal Influenza Vaccine Sales Volume and Market Share by Type
    4.3 Japan Seasonal Influenza Vaccine Sales Volume and Market Share by Application

5 South Korea Seasonal Influenza Vaccine (Volume, Value and Sales Price)
    5.1 South Korea Seasonal Influenza Vaccine Sales and Value (2012-2017)
        5.1.1 South Korea Seasonal Influenza Vaccine Sales Volume and Growth Rate (2012-2017)
        5.1.2 South Korea Seasonal Influenza Vaccine Revenue and Growth Rate (2012-2017)
        5.1.3 South Korea Seasonal Influenza Vaccine Sales Price Trend (2012-2017)
    5.2 South Korea Seasonal Influenza Vaccine Sales Volume and Market Share by Type
    5.3 South Korea Seasonal Influenza Vaccine Sales Volume and Market Share by Application

6 Taiwan Seasonal Influenza Vaccine (Volume, Value and Sales Price)
    6.1 Taiwan Seasonal Influenza Vaccine Sales and Value (2012-2017)
        6.1.1 Taiwan Seasonal Influenza Vaccine Sales Volume and Growth Rate (2012-2017)
        6.1.2 Taiwan Seasonal Influenza Vaccine Revenue and Growth Rate (2012-2017)
        6.1.3 Taiwan Seasonal Influenza Vaccine Sales Price Trend (2012-2017)
    6.2 Taiwan Seasonal Influenza Vaccine Sales Volume and Market Share by Type
    6.3 Taiwan Seasonal Influenza Vaccine Sales Volume and Market Share by Application

7 India Seasonal Influenza Vaccine (Volume, Value and Sales Price)
    7.1 India Seasonal Influenza Vaccine Sales and Value (2012-2017)
        7.1.1 India Seasonal Influenza Vaccine Sales Volume and Growth Rate (2012-2017)
        7.1.2 India Seasonal Influenza Vaccine Revenue and Growth Rate (2012-2017)
        7.1.3 India Seasonal Influenza Vaccine Sales Price Trend (2012-2017)
    7.2 India Seasonal Influenza Vaccine Sales Volume and Market Share by Type
    7.3 India Seasonal Influenza Vaccine Sales Volume and Market Share by Application

8 Southeast Asia Seasonal Influenza Vaccine (Volume, Value and Sales Price)
    8.1 Southeast Asia Seasonal Influenza Vaccine Sales and Value (2012-2017)
        8.1.1 Southeast Asia Seasonal Influenza Vaccine Sales Volume and Growth Rate (2012-2017)
        8.1.2 Southeast Asia Seasonal Influenza Vaccine Revenue and Growth Rate (2012-2017)
        8.1.3 Southeast Asia Seasonal Influenza Vaccine Sales Price Trend (2012-2017)
    8.2 Southeast Asia Seasonal Influenza Vaccine Sales Volume and Market Share by Type
    8.3 Southeast Asia Seasonal Influenza Vaccine Sales Volume and Market Share by Application

9 Australia Seasonal Influenza Vaccine (Volume, Value and Sales Price)
    9.1 Australia Seasonal Influenza Vaccine Sales and Value (2012-2017)
        9.1.1 Australia Seasonal Influenza Vaccine Sales Volume and Growth Rate (2012-2017)
        9.1.2 Australia Seasonal Influenza Vaccine Revenue and Growth Rate (2012-2017)
        9.1.3 Australia Seasonal Influenza Vaccine Sales Price Trend (2012-2017)
    9.2 Australia Seasonal Influenza Vaccine Sales Volume and Market Share by Type
    9.3 Australia Seasonal Influenza Vaccine Sales Volume and Market Share by Application

10 Asia-Pacific Seasonal Influenza Vaccine Players/Suppliers Profiles and Sales Data
    10.1 GSK
        10.1.1 Company Basic Information, Manufacturing Base and Competitors
        10.1.2 Seasonal Influenza Vaccine Product Category, Application and Specification
            10.1.2.1 Product A
            10.1.2.2 Product B
        10.1.3 GSK Seasonal Influenza Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        10.1.4 Main Business/Business Overview
    10.2 Sinovac
        10.2.1 Company Basic Information, Manufacturing Base and Competitors
        10.2.2 Seasonal Influenza Vaccine Product Category, Application and Specification
            10.2.2.1 Product A
            10.2.2.2 Product B
        10.2.3 Sinovac Seasonal Influenza Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        10.2.4 Main Business/Business Overview
    10.3 Changsheng
        10.3.1 Company Basic Information, Manufacturing Base and Competitors
        10.3.2 Seasonal Influenza Vaccine Product Category, Application and Specification
            10.3.2.1 Product A
            10.3.2.2 Product B
        10.3.3 Changsheng Seasonal Influenza Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        10.3.4 Main Business/Business Overview
    10.4 CCBIO
        10.4.1 Company Basic Information, Manufacturing Base and Competitors
        10.4.2 Seasonal Influenza Vaccine Product Category, Application and Specification
            10.4.2.1 Product A
            10.4.2.2 Product B
        10.4.3 CCBIO Seasonal Influenza Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        10.4.4 Main Business/Business Overview
    10.5 Aleph Biomedical
        10.5.1 Company Basic Information, Manufacturing Base and Competitors
        10.5.2 Seasonal Influenza Vaccine Product Category, Application and Specification
            10.5.2.1 Product A
            10.5.2.2 Product B
        10.5.3 Aleph Biomedical Seasonal Influenza Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        10.5.4 Main Business/Business Overview
    10.6 Sanofi
        10.6.1 Company Basic Information, Manufacturing Base and Competitors
        10.6.2 Seasonal Influenza Vaccine Product Category, Application and Specification
            10.6.2.1 Product A
            10.6.2.2 Product B
        10.6.3 Sanofi Seasonal Influenza Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        10.6.4 Main Business/Business Overview
    10.7 Lanzhou Institute Of Biological Product
        10.7.1 Company Basic Information, Manufacturing Base and Competitors
        10.7.2 Seasonal Influenza Vaccine Product Category, Application and Specification
            10.7.2.1 Product A
            10.7.2.2 Product B
        10.7.3 Lanzhou Institute Of Biological Product Seasonal Influenza Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        10.7.4 Main Business/Business Overview
    10.8 Siobp
        10.8.1 Company Basic Information, Manufacturing Base and Competitors
        10.8.2 Seasonal Influenza Vaccine Product Category, Application and Specification
            10.8.2.1 Product A
            10.8.2.2 Product B
        10.8.3 Siobp Seasonal Influenza Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        10.8.4 Main Business/Business Overview
    10.9 Hualan Bio
        10.9.1 Company Basic Information, Manufacturing Base and Competitors
        10.9.2 Seasonal Influenza Vaccine Product Category, Application and Specification
            10.9.2.1 Product A
            10.9.2.2 Product B
        10.9.3 Hualan Bio Seasonal Influenza Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        10.9.4 Main Business/Business Overview
    10.10 Tianyuan Bio-Pharma
        10.10.1 Company Basic Information, Manufacturing Base and Competitors
        10.10.2 Seasonal Influenza Vaccine Product Category, Application and Specification
            10.10.2.1 Product A
            10.10.2.2 Product B
        10.10.3 Tianyuan Bio-Pharma Seasonal Influenza Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        10.10.4 Main Business/Business Overview
    10.11 Vaxtec
    10.12 Hissen
    10.13 Abbott
    10.14 Novartis
    10.15 Tasly&Jenner
    10.16 Tiantan

11 Seasonal Influenza Vaccine Manufacturing Cost Analysis
    11.1 Seasonal Influenza Vaccine Key Raw Materials Analysis
        11.1.1 Key Raw Materials
        11.1.2 Price Trend of Key Raw Materials
        11.1.3 Key Suppliers of Raw Materials
        11.1.4 Market Concentration Rate of Raw Materials
    11.2 Proportion of Manufacturing Cost Structure
        11.2.1 Raw Materials
        11.2.2 Labor Cost
        11.2.3 Manufacturing Expenses
    11.3 Manufacturing Process Analysis of Seasonal Influenza Vaccine

12 Industrial Chain, Sourcing Strategy and Downstream Buyers
    12.1 Seasonal Influenza Vaccine Industrial Chain Analysis
    12.2 Upstream Raw Materials Sourcing
    12.3 Raw Materials Sources of Seasonal Influenza Vaccine Major Manufacturers in 2016
    12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders
    13.1 Marketing Channel
        13.1.1 Direct Marketing
        13.1.2 Indirect Marketing
        13.1.3 Marketing Channel Development Trend
    13.2 Market Positioning
        13.2.1 Pricing Strategy
        13.2.2 Brand Strategy
        13.2.3 Target Client
    13.3 Distributors/Traders List

14 Market Effect Factors Analysis
    14.1 Technology Progress/Risk
        14.1.1 Substitutes Threat
        14.1.2 Technology Progress in Related Industry
    14.2 Consumer Needs/Customer Preference Change
    14.3 Economic/Political Environmental Change

15 Asia-Pacific Seasonal Influenza Vaccine Market Forecast (2017-2022)
    15.1 Asia-Pacific Seasonal Influenza Vaccine Sales Volume, Revenue and Price Forecast (2017-2022)
        15.1.1 Asia-Pacific Seasonal Influenza Vaccine Sales Volume and Growth Rate Forecast (2017-2022)
        15.1.2 Asia-Pacific Seasonal Influenza Vaccine Revenue and Growth Rate Forecast (2017-2022)
        15.1.3 Asia-Pacific Seasonal Influenza Vaccine Price and Trend Forecast (2017-2022)
    15.2 Asia-Pacific Seasonal Influenza Vaccine Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
        15.2.1 Asia-Pacific Seasonal Influenza Vaccine Sales Volume and Growth Rate Forecast by Region (2017-2022)
        15.2.2 Asia-Pacific Seasonal Influenza Vaccine Revenue and Growth Rate Forecast by Region (2017-2022)
        15.2.3 China Seasonal Influenza Vaccine Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.4 Japan Seasonal Influenza Vaccine Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.5 South Korea Seasonal Influenza Vaccine Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.6 Taiwan Seasonal Influenza Vaccine Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.7 India Seasonal Influenza Vaccine Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.8 Southeast Asia Seasonal Influenza Vaccine Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.9 Australia Seasonal Influenza Vaccine Sales, Revenue and Growth Rate Forecast (2017-2022)
    15.3 Asia-Pacific Seasonal Influenza Vaccine Sales, Revenue and Price Forecast by Type (2017-2022)
        15.3.1 Asia-Pacific Seasonal Influenza Vaccine Sales Forecast by Type (2017-2022)
        15.3.2 Asia-Pacific Seasonal Influenza Vaccine Revenue Forecast by Type (2017-2022)
        15.3.3 Asia-Pacific Seasonal Influenza Vaccine Price Forecast by Type (2017-2022)
    15.4 Asia-Pacific Seasonal Influenza Vaccine Sales Forecast by Application (2017-2022)

16 Research Findings and Conclusion

17 Appendix
    17.1 Methodology/Research Approach
        17.1.1 Research Programs/Design
        17.1.2 Market Size Estimation
        17.1.3 Market Breakdown and Data Triangulation
    17.2 Data Source
        17.2.1 Secondary Sources
        17.2.2 Primary Sources
    17.3 Disclaimer